Jiren Yu

1.7k total citations
56 papers, 960 citations indexed

About

Jiren Yu is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Jiren Yu has authored 56 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 22 papers in Gastroenterology and 20 papers in Surgery. Recurrent topics in Jiren Yu's work include Gastric Cancer Management and Outcomes (26 papers), Gastrointestinal Tumor Research and Treatment (22 papers) and Metastasis and carcinoma case studies (11 papers). Jiren Yu is often cited by papers focused on Gastric Cancer Management and Outcomes (26 papers), Gastrointestinal Tumor Research and Treatment (22 papers) and Metastasis and carcinoma case studies (11 papers). Jiren Yu collaborates with scholars based in China, Japan and United States. Jiren Yu's co-authors include Xiaosun Liu, Hailong Jin, Geer Zhang, Xianke Lin, Xiaomei Huang, Jianyi Sun, Hang Yu, Qing Zhang, Weili Yang and Hang Yu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jiren Yu

53 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiren Yu China 19 352 311 285 230 205 56 960
Yangsoon Park South Korea 20 475 1.3× 390 1.3× 279 1.0× 301 1.3× 67 0.3× 59 1.2k
Kejian Guo China 18 296 0.8× 305 1.0× 339 1.2× 543 2.4× 126 0.6× 49 1.2k
Xiaosun Liu China 14 267 0.8× 207 0.7× 175 0.6× 120 0.5× 175 0.9× 25 647
Hisatoshi Nakagawara Japan 21 517 1.5× 341 1.1× 211 0.7× 485 2.1× 97 0.5× 68 1.1k
Hiroyuki Konomi Japan 17 495 1.4× 410 1.3× 330 1.2× 535 2.3× 99 0.5× 49 1.0k
Nisha Nanda United States 14 235 0.7× 561 1.8× 286 1.0× 137 0.6× 119 0.6× 33 1.4k
Hisahiro Hosogi Japan 18 638 1.8× 563 1.8× 328 1.2× 484 2.1× 246 1.2× 58 1.4k
Kyung Han Nam South Korea 14 428 1.2× 346 1.1× 227 0.8× 137 0.6× 99 0.5× 46 832
Tingyu Mou China 19 513 1.5× 617 2.0× 508 1.8× 360 1.6× 259 1.3× 48 1.5k
Guoqing Liao China 18 316 0.9× 502 1.6× 511 1.8× 215 0.9× 43 0.2× 56 1.2k

Countries citing papers authored by Jiren Yu

Since Specialization
Citations

This map shows the geographic impact of Jiren Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiren Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiren Yu more than expected).

Fields of papers citing papers by Jiren Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiren Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiren Yu. The network helps show where Jiren Yu may publish in the future.

Co-authorship network of co-authors of Jiren Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiren Yu. A scholar is included among the top collaborators of Jiren Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiren Yu. Jiren Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhou, et al.. (2023). Gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis. Scandinavian Journal of Gastroenterology. 59(2). 239–245.
2.
Xu, Liangliang, Weili Yang, César Serrano, et al.. (2023). Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166690–166690. 7 indexed citations
3.
4.
Li, Jiazheng, Hui Zhu, Chunhui Shou, et al.. (2023). CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors. European Radiology. 34(6). 3659–3670. 1 indexed citations
5.
Shi, Xiaoxiao, Zhou Chen, Weili Yang, et al.. (2023). The prognostic role of gastrointestinal bleeding in patients with a primary gastrointestinal stromal tumor: a long-term follow-up study. Journal of Gastrointestinal Oncology. 14(5). 2028–2038. 1 indexed citations
6.
Zhang, Peng, Haibo Qiu, Yong Fang, et al.. (2023). Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China. Advances in Therapy. 40(9). 3817–3829. 4 indexed citations
7.
Yang, Weili, Jiren Yu, Xiaodong Wang, et al.. (2022). Elevated preoperative controlling nutritional status (CONUT) scores as a predictor of postoperative recurrence in gastrointestinal stromal tumors. Journal of Surgical Oncology. 126(7). 1191–1198. 1 indexed citations
8.
Yang, Weili, Zhou Chen, Hang Yu, et al.. (2022). Reassessment of the recurrence risk of primary gastrointestinal stromal tumour after complete resection. Scandinavian Journal of Gastroenterology. 58(6). 684–692. 2 indexed citations
9.
10.
Jin, Hailong, et al.. (2021). The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma. Journal of the Korean Gastric Cancer Association. 21(1). 49–49. 4 indexed citations
11.
Jin, Hailong, et al.. (2020). ypT0 gastric carcinoma after preoperative chemotherapy: a unique status according to AJCC 8th edition cancer staging system. Translational Cancer Research. 9(12). 7384–7393. 3 indexed citations
12.
Liu, Xiaosun, Xianke Lin, Ying Mei, et al.. (2019). Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer. Frontiers in Immunology. 10. 1741–1741. 41 indexed citations
13.
Dong, Shuai, Jiren Yu, Qin Zhang, & Xiaosun Liu. (2015). Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population. Journal of Chemotherapy. 28(1). 59–64. 13 indexed citations
14.
Liu, Xiaosun, Hailong Jin, Geer Zhang, et al.. (2014). Intratumor IL-17-Positive Mast Cells Are the Major Source of the IL-17 That Is Predictive of Survival in Gastric Cancer Patients. PLoS ONE. 9(9). e106834–e106834. 49 indexed citations
15.
Yang, Weili, Jiren Yu, Yuan Gao, et al.. (2014). Preoperative imatinib facilitates complete resection of locally advanced primary GIST by a less invasive procedure. Medical Oncology. 31(9). 133–133. 6 indexed citations
16.
Zhang, Zhongwei, et al.. (2013). Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer. PLoS ONE. 8(3). e58990–e58990. 18 indexed citations
17.
Jin, Hailong, Geer Zhang, Xiaosun Liu, et al.. (2013). Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. World Journal of Surgical Oncology. 11(1). 112–112. 65 indexed citations
18.
Wu, Yijun, Qi Li, Xinhui Zhou, et al.. (2012). Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer. PLoS ONE. 7(4). e35684–e35684. 25 indexed citations
19.
Yang, Weili, Jiren Yu, Yijun Wu, et al.. (2009). Duodenal gastrointestinal stromal tumor: Clinical, pathologic, immunohistochemical characteristics, and surgical prognosis. Journal of Surgical Oncology. 100(7). 606–610. 41 indexed citations
20.
Yamaguchi, Akio, Takanori Goi, Jiren Yu, et al.. (2002). Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long‐term prognosis. Journal of Surgical Oncology. 79(4). 230–235. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangsoon Park Breakdown of academic impact, for papers by Kejian Guo Breakdown of academic impact, for papers by Xiaosun Liu Breakdown of academic impact, for papers by Hisatoshi Nakagawara Breakdown of academic impact, for papers by Hiroyuki Konomi Breakdown of academic impact, for papers by Nisha Nanda Breakdown of academic impact, for papers by Hisahiro Hosogi Breakdown of academic impact, for papers by Kyung Han Nam Breakdown of academic impact, for papers by Tingyu Mou Breakdown of academic impact, for papers by Guoqing Liao
Rankless by CCL
2026